UBS Group’s XTL Biopharmaceuticals XTLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52K | Buy |
+1,336
| New | +$1.52K | ﹤0.01% | 8278 |
|
|
2024
Q2 | – | Sell |
-6,954
| Closed | -$19.5K | – | 8842 |
|
|
2024
Q1 | $19.5K | Buy |
6,954
+6,900
| +12,778% | +$19.4K | ﹤0.01% | 5768 |
|
|
2023
Q4 | $55 | Sell |
54
-66
| -55% | -$67 | ﹤0.01% | 7769 |
|
|
2023
Q3 | $108 | Buy |
+120
| New | +$108 | ﹤0.01% | 7713 |
|
|
2023
Q1 | – | Sell |
-300
| Closed | -$363 | – | 9104 |
|
|
2022
Q4 | $363 | Buy |
+300
| New | +$363 | ﹤0.01% | 9025 |
|
|
2022
Q2 | – | Sell |
-812
| Closed | -$2K | – | 9805 |
|
|
2022
Q1 | $2K | Buy |
812
+658
| +427% | +$1.62K | ﹤0.01% | 8624 |
|
|
2021
Q4 | $0 | Sell |
154
-2,744
| -95% | – | ﹤0.01% | 9449 |
|
|
2021
Q3 | $13K | Buy |
+2,898
| New | +$13K | ﹤0.01% | 6554 |
|
|
2021
Q2 | – | Sell |
-3,524
| Closed | -$12K | – | 8632 |
|
|
2021
Q1 | $12K | Buy |
+3,524
| New | +$12K | ﹤0.01% | 6789 |
|
|
2020
Q4 | – | Sell |
-1,036
| Closed | -$2K | – | 7676 |
|
|
2020
Q3 | $2K | Buy |
+1,036
| New | +$2K | ﹤0.01% | 6812 |
|
|
2020
Q1 | – | Sell |
-1,224
| Closed | -$2K | – | 7268 |
|
|
2019
Q4 | $2K | Sell |
1,224
-2,104
| -63% | -$3.44K | ﹤0.01% | 6775 |
|
|
2019
Q3 | $5K | Sell |
3,328
-200
| -6% | -$300 | ﹤0.01% | 6525 |
|
|
2019
Q2 | $7K | Sell |
3,528
-2,800
| -44% | -$5.56K | ﹤0.01% | 6378 |
|
|
2019
Q1 | $15K | Sell |
6,328
-343
| -5% | -$813 | ﹤0.01% | 5720 |
|
|
2018
Q4 | $12K | Buy |
6,671
+216
| +3% | +$389 | ﹤0.01% | 6226 |
|
|
2018
Q3 | $14K | Buy |
6,455
+5,763
| +833% | +$12.5K | ﹤0.01% | 6090 |
|
|
2018
Q2 | $1K | Sell |
692
-437
| -39% | -$632 | ﹤0.01% | 6914 |
|
|
2018
Q1 | $2K | Buy |
1,129
+426
| +61% | +$755 | ﹤0.01% | 6661 |
|
|
2017
Q4 | $2K | Sell |
703
-2,337
| -77% | -$6.65K | ﹤0.01% | 6651 |
|
|
2017
Q3 | $7K | Sell |
3,040
-13,269
| -81% | -$30.6K | ﹤0.01% | 6168 |
|
|
2017
Q2 | $52K | Buy |
16,309
+10,989
| +207% | +$35K | ﹤0.01% | 4702 |
|
|
2017
Q1 | $14K | Buy |
5,320
+1,932
| +57% | +$5.08K | ﹤0.01% | 5491 |
|
|
2016
Q4 | $11K | Buy |
+3,388
| New | +$11K | ﹤0.01% | 5913 |
|
|
2016
Q1 | – | Sell |
-73
| Closed | -$1K | – | 6894 |
|
|
2015
Q4 | $1K | Sell |
73
-268
| -79% | -$3.67K | ﹤0.01% | 6729 |
|
|
2015
Q3 | $3K | Buy |
+341
| New | +$3K | ﹤0.01% | 6482 |
|
|
2015
Q2 | – | Sell |
-605
| Closed | -$7K | – | 6908 |
|
|
2015
Q1 | $7K | Buy |
605
+290
| +92% | +$3.36K | ﹤0.01% | 6063 |
|
|
2014
Q4 | $3K | Buy |
+315
| New | +$3K | ﹤0.01% | 6526 |
|